CAGR: 6.5%Current Market Size: USD 3.16 BillionFastest Growing Region: APAC
Largest Market: North AmericaProjection Time: 2023-2030Base Year: 2022
The global veterinary artificial insemination market is expected to grow from USD 3.16 billion in 2022 to USD 5.22 billion by 2030, at a CAGR of 6.5% during the Projection period 2023-2030. The growth of the veterinary artificial insemination market is mainly driven by the rising need for enhanced animal productivity
The process of establishing pregnancy without sexual contact by introducing sperm or semen into the feminine cervix or endometrial canal is known as artificial insemination. It is a method of breeding cattle that use fresh, undercooked, or frozen grains of sperm. Artificial insemination is a process of in vivo fertilisation used to establish animal pregnancy. This process is also used in assisted reproduction and reproductive technology, and it allows animals to mate on time throughout their heat cycle. Veterinary artificial insemination is an effective technology tool for improving the genetics and fertility of animals. The increased rate of genetic creation and animal processing utilizing AI in various locations is supporting the growth of the veterinary artificial insemination industry. Artificial insemination is a sort of assisted reproductive treatment in which sperm from a female's cervix, reproductive organs, or uterus is implanted. It is performed by brief and relatively painless donor sperm artificial insemination (AID) procedures. Self-insemination kits are now available for purchase and can be used in the privacy of one's own home. Artificial insemination is now widely employed in farming animals to boost reproductive success and preserve rare and endangered species. It also prevents the spread of certain illnesses and sterility in animals due to genital issues. In animal species such as cattle, domesticated animals, and biodiversity, artificial insemination is utilized for artificial selection, genetic progress, infertility treatment, and species preservation.
Sample Request: - Global Veterinary Artificial Insemination Market
Market Dynamics:
Drivers:
Artificial insemination has been demonstrated to be a successful therapy available to cow farmers, which only adds to the long-term profitability of cattle operations, as well as additional connected benefits such as lower reproduction risks, which are some of the causes driving market expansion. This method is preferred over spontaneous mating because sperm can be easily transmitted, allowing more females to be fertile and pregnant in different geographical regions at the same time. Furthermore, the sperm can be saved, diluted, and used to create many dosages capable of inseminating 100 females from a single discharge. As this method gets more popular, most producers gather semen and sell it to other manufacturers.
Restraints:
Antibodies found in the bloodstreams of reproductive sires used for sperm collection are checked on a regular basis because they suggest a previous sickness. Some infections, such as the horse arteritis virus, can persist in sperm for several weeks before generating immunoreactivity. The sperm of such organisms can pass on conditions to naive females. This is limiting demand and is projected to impede the global artificial insemination market's growth throughout the Projection period.
Opportunities:
Industry heavyweights such as Sanofi, Zoetis, and Boehringer Ingelheim today dominate the global animal insemination business. In the artificial insemination industry, reagents and media categories contribute to more exceptional revenue growth rates for all top rivals. Other AI products, including as kits and catheters, are primarily sold by small businesses like Swine Genetics Jorgensen Labs Continental Plastic Corporation and offer considerable growth chances to leverage on opportunities in the instruments industry at regional and global markets.
Challenges:
Fresh sperm concentration, sperm density, and seminal hemoglobin level during final dilution may all affect the longevity of low sperm dosages. One problem of employing low sperm dosages is that their viability and potency are lowered, which is one of the drawbacks of effective artificial insemination treatments. To achieve optimal fertility, a specific number of sperm is necessary per artificial insemination. This is an important aspect of the artificial insemination industry, and it has space for growth.
Segmentation Analysis:
The global veterinary artificial insemination market has been segmented based on animal type, product, end-user, and region.
By Animal Type
The animal type segment is equine, cattle, swine, ovine & caprine, and others. The swine segment led the largest share of the veterinary artificial insemination market with a market share of around 40.23% in 2022. Due to advances in bovine and swine genetics, extensive use of AI in cattle and pig breeding across key markets, and the need to produce sustainable animals. DanBred, situated in Denmark, for example, uses DanBred AI to provide superior bovine genetics. GenePro can follow the genetic advancement of the sperm and the herd for improved accountability and ROI. The genetic base change statistics, which quantify the actual progress made for each feature within a breed, can be used to evaluate advances in bovine genetics. The modified Predicted Transmitting Abilities (PTAs) for each characteristic and animal in a breed are represented by the base change. Every five years, the number is reset to zero.
By Product
The product segment is sexed semen and normal semen. The sexed semen segment led the largest share of the veterinary artificial insemination market with a market share of around 61.3% in 2022. This is owing to increased use to accelerate herd expansion and favorable government legislation. The Indian government subsidized the price of sexed sperm straws in June 2021. This collaboration between the government and Genus ABS would benefit dairy farmers in Maharashtra, India, by lowering the price of sex-sorted sperm from USD 17.50 to USD 1. The Agriculture and Horticulture Development Board in the United Kingdom also reported an increase in sexed sperm sales in 2020 due to improved success rates and competitive pricing.
By End-User
The end-user segment is animal husbandry and others. The animal husbandry segment led the largest share of the veterinary artificial insemination market with a market share of around 58.3% in 2022. The majority of the semen collection and AI operations are performed on-site in breeding farms, which accounts for the rise. Furthermore, rising government initiatives, technological breakthroughs, and demand for milk and protein are growing AI technology use. For example, the Indian government granted approximately USD 2.06 billion to the Animal Husbandry Infrastructure Development Fund in June 2020. (AHIDF). Alibaba Cloud, DEKON Group, and Sichuan Tequ Group cooperated in February 2018 to employ ET Brain technology for pig breeding in China.
Global Veterinary Artificial Insemination Market - Sales Analysis.
The sale of the veterinary artificial insemination market expanded at a CAGR of 4.1% from 2016 to 2022.
Animal development has recently been achieved by the use of Artificial Insemination, which is utilised to raise awareness about sexually transmitted diseases (STD) in animals. This component is the primary driver of market expansion. The primary advantage of artificial insemination that is expected to boost the global market over the predicted years is reduced breeding-related hazards. According to an International Society for Animal Genetics research, artificial insemination is favoured over natural mating because semen may be conveniently transported. Producers harvest better herd sperm and make it available to other producers. Producers can use this strategy to decide which qualities to breed into their animals.
This approach is gaining popularity and is likely to generate potential growth possibilities during the Projection period. Natural mating is less sanitary than artificial insemination. The growing human population is also a major factor contributing to the ongoing requirement for increased animal productivity.
Thus, owing to the aforementioned factors, the global veterinary artificial insemination market is expected to grow at a CAGR of 6.5% during the Projection period from 2023 to 2030.
By Regional Analysis:
The regions analyzed for the veterinary artificial insemination market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America region dominated the veterinary artificial insemination market and held a 39% share of the market revenue in 2022.
Global Veterinary Artificial Insemination Market - Country Analysis:
Germany's veterinary artificial insemination market size was valued at USD 0.22 billion in 2022 and is expected to reach USD 0.36 billion by 2030, at a CAGR of 6.6% from 2023 to 2030. Increased knowledge of veterinary artificial insemination and an increase in the prevalence of infectious diseases in animals are driving the region's market. Germany's high market share is due to its large cattle population. Other factors boosting the region's market growth include an increase in dairy and animal-based protein consumption, as well as government initiatives.
China’s veterinary artificial insemination market size was valued at USD 0.24 billion in 2022 and is expected to reach USD 0.40 billion by 2030, at a CAGR of 6.9% from 2023 to 2030. Growing infectious illnesses in animals and increased public knowledge about artificial insemination are the primary factors driving the Asia-Pacific veterinary artificial insemination market growth. Countries in Asia, such as China, have been badly impacted by the COVID-19 outbreak.
India's veterinary artificial insemination market size was valued at USD 0.18 billion in 2022 and is expected to reach USD 0.30 billion by 2030, at a CAGR of 6.8% from 2023 to 2030. According to the Animal Husbandry, Dairy, and Fisheries Department 2020-2021 report, in India, the department adopted the innovative method of sexing the semen, in which the sperm responsible for the birth of male calves is sorted and destroyed, resulting in the production of solely female calves. Furthermore, the government has suggested testing new technology by utilizing 2,000 such semen doses for artificial insemination in farmer's animals on a trial basis. For example, in August 2019, Madras Veterinary College's Obstetrics and the Department of Veterinary, Gynecology began artificial insemination in cattle using sexed sperm. As a result, the aforementioned factors are likely to propel market expansion in the region.
Key Industry Players Analysis:
To increase their market position in the global veterinary artificial insemination market business, top companies focus on tactics such as adopting new technology, mergers & acquisitions, product developments, collaborations, partnerships, joint ventures, etc.
Latest Development:
Report Metrics
Report Attribute |
Details |
Study Period |
2022-2030 |
Base year |
2022 |
CAGR (%) |
6.5% |
Market Size |
3.16 billion in 2022 |
Projection period |
2023-2030 |
Projection unit |
Value (USD) |
Segments covered |
By Animal Type, By Product, By End-User, and By Region. |
Report Scope |
Revenue Projection, competitive landscape, company ranking, growth factors, and trends |
Companies covered |
Genus, Viking Genetics, URUS Group LP, CRV, SEMEX, Swine Genetics International, Select Sires Inc., Stallion AI Services Ltd, Shipley Swine Genetics, and Stgenetics. |
By Animal Type |
|
By Product |
|
By End-User |
|
Regional scope |
|
Scope of the Report
Global Veterinary Artificial Insemination Market By Animal Type:
Global Veterinary Artificial Insemination Market By Product:
Global Veterinary Artificial Insemination Market By End-User:
Global Veterinary Artificial Insemination Market By Region:
Global veterinary artificial insemination market is expected to reach USD 5.22 billion by 2030.
The veterinary artificial insemination market is projected to have a CAGR of 6.5%.
Artificial insemination has been demonstrated to be a successful therapy available to cow farmers, which only adds to the long-term profitability of cattle operations, as well as additional connected benefits such as lower reproduction risks, which are some of the causes driving market expansion.
Leading market players active in the global veterinary artificial insemination market are Genus, Viking Genetics, URUS Group LP, CRV, SEMEX, Swine Genetics International, Select Sires Inc., Stallion AI Services Ltd, Shipley Swine Genetics, STgenetics among others.
Political Factors- Before deciding whether to expand, the veterinary artificial insemination market should carefully study the tax legislation that applies to the business. Tax policy will help more sectors that the government considers critical priorities. Many developing countries aggressively pursue tax breaks for corporations in order to attract foreign direct investment. These countries should be considered in the veterinary artificial insemination market because they have low tax rates, making it easier to make money and invest in R&D, innovation, and new product development activities.
Economic Factors- Capital accumulation and the production of goods and services are made possible by the efficiency of the financial market and general economic growth, which have a strong positive relationship. To fast accumulate financial and human resources, the veterinary artificial insemination market must choose countries with extremely successful financial markets. By monitoring the effectiveness of the financial market, the veterinary artificial insemination market may be able to keep one step ahead of the competition. Rising inflation diminishes the purchasing power of money and discourages people from purchasing products and services, which may have a negative influence on the veterinary artificial insemination industry's capacity to raise revenue.
Social Factors- Respect for hierarchy and social class stratification are two major social qualities that may have an impact on the veterinary artificial insemination market's commercial, marketing, and human resource management strategies. When traveling to countries with considerable power disparities, the veterinary artificial insemination market feels most at home in hierarchical organizations with formal work cultures. The veterinary artificial insemination industry cannot target many groups from distinct social classes with the same marketing mix, highlighting the importance of effective market segmentation techniques.
Technological Factors- The rate and advancement of technological innovation may have an impact on the market and industry as a whole. By analyzing upcoming technological innovation trends, the veterinary artificial insemination market will be able to comprehend the rate of new product creation, the length of the product life cycle, and the specific characteristics consumers need. By analyzing consumer attitudes toward cutting-edge, new digital technologies, the veterinary pain management market can assess whether converting to e-commerce will be more advantageous than building a physical site. If competitors embrace automation technology to cut costs, the veterinary artificial insemination market may be driven to convert from manual to automated processes—especially if the general populace is digitally savvy.
Environmental Factors- Businesses are under pressure to reduce their environmental impact as a result of stringent environmental legislation in a variety of countries. In response, the veterinary artificial insemination market should adopt ethical production methods, encourage ethical consumption among its target market, work to improve its brand's long-term reputation, and ensure full compliance with local and international environmental laws, as failure to do so, may result in harsh, reputation-damaging criticism from relevant stakeholders. Businesses that generate a significant amount of waste may be obligated by law to control their environmental practices.
Legal Factors- Several federal and state laws are in existence in several countries to protect consumers from potential economic exploitation. In the age of digital technology, consumer privacy laws have become more stringent. To avoid lawsuits, the veterinary artificial insemination industry must closely adhere to data privacy rules when conducting online transactions. Before entering new markets, Market Management must research local rules governing refunds, discounts, credit terms, quality, misleading advertising, and maximum pricing (particularly in the case of basic essential goods).
List of Table
List of Figures